|
Volumn 88, Issue 3, 2013, Pages 240-241
|
Pure Erythroid Leukemia Evolving From A Therapy-Related Myelodysplastic Syndrome Secondary To Treatment For Chronic Lymphocytic Leukemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZACITIDINE;
CLADRIBINE;
CYCLOPHOSPHAMIDE;
FLUDARABINE;
GLYCOPHORIN;
PREDNISONE;
VINCRISTINE;
AGED;
BONE MARROW BIOPSY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER CYTODIAGNOSIS;
CANCER MORTALITY;
CANCER PALLIATIVE THERAPY;
CASE REPORT;
CHRONIC LYMPHATIC LEUKEMIA;
DISEASE COURSE;
ERYTHROBLAST;
ERYTHROID CELL;
FEVER;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
LEUKEMIA;
MALE;
MULTIPLE CYCLE TREATMENT;
MYELODYSPLASTIC SYNDROME;
NOTE;
PANCYTOPENIA;
PRIORITY JOURNAL;
PURE ERYTHROID LEUKEMIA;
REFRACTORY THROMBOCYTOPENIA;
ABNORMAL KARYOTYPE;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLADRIBINE;
CYCLOPHOSPHAMIDE;
FATAL OUTCOME;
HUMANS;
LEUKEMIA, ERYTHROBLASTIC, ACUTE;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
MALE;
MYELODYSPLASTIC SYNDROMES;
PREDNISONE;
VIDARABINE;
VINCRISTINE;
|
EID: 84874311730
PISSN: 03618609
EISSN: 10968652
Source Type: Journal
DOI: 10.1002/ajh.23224 Document Type: Note |
Times cited : (9)
|
References (4)
|